top of page
Microscope
Industry
Life Sciences
​

The life sciences sector is experiencing unprecedented growth, driven by advancements in biotechnology, genomics, and personalized medicine. We help companies secure capital to develop innovative therapies and expand their research capabilities.

 

As the industry evolves, our strategic guidance ensures firms can navigate regulatory complexities and capitalize on emerging opportunities. Significant investment is flowing into digital health and telemedicine, enhancing patient care and operational efficiency. 

 

We assist companies in raising funds to develop and implement these cutting-edge solutions. With our expertise, life sciences firms can achieve long-term growth and resilience in a dynamic healthcare landscape.

© 2026 by Schwendel - Van Deusen. All Rights Reserved.

​

​

​

Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Schwendel-Van Deusen is not a registered broker-dealer, and Finalis Securities LLC and Schwendel-Van Deusen are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.

​

Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)

​

www.schwendel-vandeusen.com (the "Schwendel-Van Deusen Website") is a website operated by Schwendel-Van Deusen. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Schwendel-Van Deusen along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.

​

Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.

​

​

bottom of page